- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Acura Pharmaceuticals Inc
+ Add to WatchlistACUR:US
2.3400 USD 0.0400 1.74%As of 20:10:00 ET on 05/22/2013.
Company Profile for Acura Pharmaceuticals Inc (ACUR)
Acura Pharmaceuticals Inc. is a pharmaceutical technology development company. The Company researches, develops, and manufactures active pharmaceutical ingredients (APIs) used as raw materials in the production of pharmaceutical products. Acura has developed technologies for use in narcotic-based pain management products.
Contact Information
Acura Pharmaceuticals Inc
616 N North Court
Suite 120
Palatine, IL 60067
United States
Key Executives for Acura Pharmaceuticals Inc (ACUR)
| Robert B JonesPresident/CEO | Peter A ClemensSenior VP/CFO/Secretary |
| Robert A SeiserVP/Treasurer/Controller | Albert W BrzeczkoVP:Technical Affairs |
| James F EmighVP:Corporate Development | J Bradley RivetVP:Marketing |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page